Содержание
- 2. Overview of Presentation Overview of the U.S. vaccine safety system Updates on a number of current
- 3. Vaccine Safety When the vaccine is under development, studies are done to find out if it
- 4. What Do VAERS Reports Mean? VAERS has led to early identification of serious adverse events Not
- 5. How Do We Decide What We Are Going to Worry About? Consistent pattern of clinical findings
- 6. A Faster Approach to Vaccine Safety Studies Alternative to traditional post-licensure vaccine safety study methods, which
- 7. Meningococcal Conjugate Vaccine and Guillain-Barré Syndrome VAERS: 24 confirmed reports among vaccine recipients 2 among persons
- 8. Timing of Onset of GBS following Meningococcal Conjugate Vaccine Onset intervals 2-33 days Mean 17.4 days
- 9. Update on Safety of Varicella Vaccine Varicella vaccine strain can establish latency like wildtype varicella and
- 10. Establishment of VZV Latency in Sensory-Nerve Ganglia Kimberlin D, Whitley R. N Engl J Med 2007;356:1338-1343
- 11. Herpes Zoster among Recipients of Varicella Vaccine VAERS: 981 reports of herpes zoster 47 of 981
- 13. Judicial Watch Investigates Side-Effects of HPV Vaccine Wed, 05/14/2008 - 14:05 — gstasiewicz "The FDA adverse
- 14. Adverse Events and HPV Vaccine: Summary Over 21 million doses distributed As of August 31, 2008,
- 15. Reports of Death Following HPV Vaccine 20 U.S. death reports; unable to follow up 7
- 16. Syncope (Fainting) following HPV Vaccine Increased reporting of syncope among vaccinees Although usually not serious, syncope
- 17. General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP) “…, although syncopal
- 18. Intussusception and RotaTeq® 9.1 million doses distributed (March 2006- August 31, 2007)* VAERS: 160 confirmed intussusception
- 19. Adverse Reactions Following MMRV and MMR+V Fever is more common in the 5-12 days after vaccination
- 20. Temporal Distribution of Seizures after MMRV Vaccination Days Post-MMRV Vaccine Number of Seizures (2/06-9/07, after 47,137
- 21. Thimerosal and Autism: What Does the Science Show? Ecologic studies: autism does not go down when
- 22. Children Receiving Autism Services by Quarter, California, 2002-2007 California Department of Developmental Services
- 23. Vaccines and Autism, Still MMR and autism (1998) Thimerosal and autism (2001) Simultaneous administration of multiple
- 24. Vaccines and Autism: Context Heuristics and biases Distrust of government Unanswered questions about autism and real
- 25. “Why doesn’t CDC study autism rates in unvaccinated children?” Almost all children in the U.S. have
- 26. Number of Vaccines in the Routine Childhood and Adolescent Immunization Schedule 1985 1995 2006 Measles Rubella
- 27. Recommended Schedule for Persons Aged 0-6 Years, U.S.
- 28. Current Parent Concerns Focus groups with first time mothers in 3 cities: Chicago, Portland, and Richmond
- 29. What Parents Are Concerned About (2008) It is painful for children to get so many shots
- 31. Why Do We Give Vaccines at the Ages We Do? To provide protection from vaccine preventable
- 32. Advisory Committee on Immunization Practices Evidence-based recommendations based on: Licensed indications and schedule Burden of disease
- 33. Missed Opportunities Definition: Healthcare encounter in which a child is eligible to receive a vaccination but
- 34. Safety and Efficacy Issues Potentially Associated with the Schedule Data generally available on concurrent administration at
- 35. Outpatient Visits for Fever by Day after Vaccine at Northern California Kaiser Permanente: 1995-2008 Vaccine Safety
- 36. Data on Simultaneous Administration for a Licensed Vaccine: ROTARIX 484 healthy infants randomized into two groups
- 37. The Science of Studying More than One Thing at a Time Rapid advances in multiple fields
- 38. Other Issues Recommendations and requirements – should everything that is recommended be required? Public health vs.
- 39. Is Our Immunization Schedule “One Size Fits All”? Contraindications and precautions do provide guidance for decision-making
- 40. SMEI and “Vaccine Encephalopathy” Epileptic encephalopathies, without other specific cause identified, with first seizure onset within
- 41. What Determines Credibility? Low Concern Settings All other factors 15-20% Competence/ Expertise 80-85% Randall Hyer, NIC,
- 42. What Determines Credibility? High Concern Settings All other factors 15-20% Competence/ Expertise 15-20% Honesty/openness 15-20% Listening/caring/
- 43. Measles Cases Reported to CDC/NCIRD January 1 to July 11, 2008 (N= 132) San Diego, CA
- 44. Invasive H. influenzae type B disease -- Minnesota, 2008 5 cases of invasive Hib disease in
- 45. Where That Leaves Us When we do more than one thing at a time, it’s complicated
- 47. Скачать презентацию